NO WONDER THEY PUBLISH SO MUCH DISINFORMATION AND BLATANT LIES ~
Robert Kennedy Jr: “CDC is a Privately Owned Vaccine Company!”
December 7, 2018 by Suzanne Maresca
By Sean Adl-Tabatabai, December 5, 2018, explainlife.com
httpss://tinyurl.com/y9u585gz
Robert F. Kennedy Jr. claims the CDC owns patents on at least 57 different vaccines, and profits $4.1 billion per year in vaccination sales.
According to RFK Jr., the CDC is not an independent government agency but is actually a subsidiary of Big Pharma.
Greenmedinfo.com reports: Mr. Kennedy told EcoWatch, “The CDC is a subsidiary of the pharmaceutical industry. The agency owns more than 20 vaccine patents and purchases and sells $4.1 billion in vaccines annually.”
Again, no source.
I have been around long enough to know that vaccine claims have to be checked and rechecked. And since this is a very old claim, one that I would like to be able to state (if it is true), I decided to review it.
I am fortunate to have, as one of my partners in advocacy, fellow autism parent Mark Blaxill, an Intellectual Property expert who has been employed by billion-dollar corporations to manage their patents. Blaxill was the man who found out that HHS, through NIH, owns patents on all HPV vaccines, and receives a percentage of the profits for each dose of Gardasil and Cervarix administered anywhere in the world. He published the stunning revelation in a detailed three-part expose entitled, “A License to Kill? Part 1: How A Public-Private Partnership Made the Government Merck’s Gardasil Partner.”
When I contacted Blaxill to ask how to run a patent search, he was kind enough to do it for me. He found 57 granted US patents with the CDC listed as an assignee. You can see the search results here. Upon cursory review of the patents, I found that one did not seem applicable to vaccination, but merely referenced an article on vaccination. That leaves us with 56 CDC patents to scrutinize.
Here is what I found.
There are CDC patents applicable to vaccines for Flu, Rotavirus, Hepatitis A, HIV, Anthrax, Rabies, Dengue fever, West Nile virus, Group A Strep, Pneumococcal disease, Meningococcal disease, RSV, Gastroenteritis, Japanese encephalitis, SARS, Rift Valley Fever, and chlamydophila pneumoniae. There is a CDC patent for “Nucleic acid vaccines for prevention of flavivirus infection,” which has applications in vaccines for Zika, West Nile virus, Dengue fever, tick-borne encephalitis virus, yellow fever, Palm Creek virus, and Parramatta River virus. CDC also has several patents for administering various ”shots” via aerosol delivery systems for vaccines.
There’s a CDC patent on a process for vaccine quality control by “quantifying proteins in a complex preparation of uni- or multivalent commercial or research vaccine preparations.”
There’s a CDC patent on a method “for producing a model for evaluating the antiretroviral effects of drugs and vaccines.”
CDC has a patent for companies who want to test their respiratory system applicable vaccine on an artificial lung system. If a vaccine maker is concerned that their vaccine might contain a human rhinovirus, CDC has a patent on a process for determining if such contamination exists.
CDC has a patent on an assay to assist vaccine makers in finding antigen-specific antibodies in a biological sample. CDC holds a patent that provides vaccine makers with a method of “reducing the replicative fitness of a pathogen by deoptimizing codons.” Asserting that, “pathogens with deoptimized codons can be used to increase the phenotypic stability of attenuated vaccines.”
The agency also holds a patent on adjuvants for a vaccine used on premature infants and young babies.
There is a CDC patent to cover a vaccine for an infection induced by a tapeworm found in pork. They even have patents that cover vaccines for animal illnesses including Canarypox virus, Fowlpox virus, Sealpox virus, dog flu and monkey cancer.
Does this seem like a public health agency making “independent” vaccine recommendations, or a private company with an impressive portfolio to which one might look for investment opportunities?
The CDC is reputed to be an independent government agency making vaccine recommendations to the public, only for the public good. They are the agency charged with vaccine safety oversight, via their Immunization Safety Office.
Here is how the office describes its charge:
“CDC’s Immunization Safety Office plays a vital role in ensuring our nation’s vaccine safety. Sound immunization policies affecting children and adults in the U.S. depend on continuous monitoring of the safety and effectiveness of vaccines. CDC uses many strategies to assess vaccine safety, to identify health problems possibly related to vaccines, and to conduct studies that help determine whether a health problem is caused by a specific vaccine. CDC also works with other federal government agencies and other stakeholders to determine the appropriate public health response to vaccine safety concerns and to communicate the benefits and risks of vaccines.
The Immunization Safety Office regularly reports on vaccine safety monitoring findings and any concerns to CDC’s Advisory Committee on Immunization Practices (ACIP). This advisory group develops the recommended vaccine schedule for children and adults in the U.S. ACIP considers the safety and effectiveness of vaccines before making recommendations to the vaccine schedule or changing recommendations for vaccine use.”
Note that they proudly state that they report to the ACIP – the same committee on which Paul Offit infamously served as if this reporting somehow adds legitimacy to their vaccine safety work. The same committee that Congress has excoriated for their long history of conflicts of interests.
Nowhere on the CDC’s web site can I find the disclosure that the agency is a profit partner with the vaccine makers for whom it is supposed to be providing safety oversight.
Mr. Kennedy is in very safe territory by reporting that the CDC has over 20 patents that create vast, undisclosed conflicts of interest in vaccine safety. He is understating the problem by more than half.
Pat Shannan, Editor